Cancer patients will have greater access to clinical trials of personalised therapies after a funding boost for specialised medical centres designed to make new treatments available as soon as possible.
Doctors and scientists at 29 experimental cancer medicine centres (ECMCs) in the UK are to receive £43m in fresh support over the next five years to trial new treatments for children and adults. These include drugs that encourage the immune system to attack tumours or prevent cancer cells from growing.
